SATELLOS BIOSCIENCE INC (MSLE) Forecast, Price Target & Analyst Ratings

NASDAQ:MSLE • CA80401L8033

Current stock price

5.87 USD
-0.17 (-2.81%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SATELLOS BIOSCIENCE INC (MSLE).

Forecast Snapshot

Consensus Price Target

Price Target
$19.95
+ 239.80% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.47
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.44%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$19.95
Upside
+ 239.80%
From current price of $5.87 to mean target of $19.95, Based on 9 analyst forecasts
Low
$10.48
Median
$19.85
High
$30.27

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for MSLE. The average price target is 19.95 USD. This implies a price increase of 239.8% is expected in the next year compared to the current price of 5.87.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MSLE Current Analyst RatingMSLE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

MSLE Historical Analyst RatingsMSLE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
84.44%
MSLE was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about MSLE.
In the previous month the buy percentage consensus was at a similar level.
MSLE was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-30HC Wainwright & Co.Maintains Buy -> Buy
2026-03-11Cantor FitzgeraldInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.47
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
1.19%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A

Next Earnings Summary

MSLE is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.47 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
MSLE revenue by date.MSLE revenue by date.
N/AN/AN/AN/A
EBITDA
YoY % growth
MSLE ebitda by date.MSLE ebitda by date.
-1.653M-4.688M
-183.70%		-5.931M
-26.51%		-11.354M
-91.43%		-20.413M
-79.79%		N/AN/AN/AN/A
EBIT
YoY % growth
MSLE ebit by date.MSLE ebit by date.
-1.656M-4.854M
-193.17%		-6.179M
-27.29%		-11.359M
-83.84%		-20.428M
-79.84%		N/A
-24.02%		N/A
-7.21%		N/A
-28.04%		N/A
Operating Margin
MSLE operating margin by date.MSLE operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
MSLE eps by date.MSLE eps by date.
N/AN/AN/A-2.28
23.04%		-2.57
-12.63%		-2.14
16.67%		N/A
35.18%		N/A
-32.35%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.47
1.19%		-0.50
0.83%		-0.46
6.71%		-0.51
23.19%		-0.37
22.58%		-0.49
2.04%		-0.49
-6.67%		-0.49
4.00%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-7.786M
-20.18%		-7.915M
-24.32%		-7.539M
-26.37%		-9.21M
-49.84%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MSLE Yearly Revenue VS EstimatesMSLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2028 2M 4M 6M
MSLE Yearly EPS VS EstimatesMSLE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5 -2 -2.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SATELLOS BIOSCIENCE INC / MSLE Forecast FAQ

What is the average price target for SATELLOS BIOSCIENCE INC (MSLE) stock?

9 analysts have analysed MSLE and the average price target is 19.95 USD. This implies a price increase of 239.8% is expected in the next year compared to the current price of 5.87.

Can you provide the upcoming earnings date for SATELLOS BIOSCIENCE INC?

SATELLOS BIOSCIENCE INC (MSLE) will report earnings on 2026-05-04.

What are the consensus estimates for MSLE stock next earnings?

The consensus EPS estimate for the next earnings of SATELLOS BIOSCIENCE INC (MSLE) is -0.47 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for MSLE stock?

The consensus rating for SATELLOS BIOSCIENCE INC (MSLE) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.